These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 36852569)
21. [Update on PONV-What is new in prophylaxis and treatment of postoperative nausea and vomiting? : Summary of recent consensus recommendations and Cochrane reviews on prophylaxis and treatment of postoperative nausea and vomiting]. Kienbaum P; Schaefer MS; Weibel S; Schlesinger T; Meybohm P; Eberhart LH; Kranke P Anaesthesist; 2022 Feb; 71(2):123-128. PubMed ID: 34596699 [TBL] [Abstract][Full Text] [Related]
22. Comparison of ondansetron and tropisetron in preventing postoperative nausea and vomiting: A meta-analysis of randomized controlled trials. Wang R; Song X; Chen Y; Wang N; Wang J Saudi Med J; 2021 Jul; 42(7):707-713. PubMed ID: 34187913 [TBL] [Abstract][Full Text] [Related]
23. 5-HT3 receptor antagonists vs traditional agents for the prophylaxis of postoperative nausea and vomiting. Loewen PS; Marra CA; Zed PJ Can J Anaesth; 2000 Oct; 47(10):1008-18. PubMed ID: 11032279 [TBL] [Abstract][Full Text] [Related]
24. Genetic factors associated with pharmacotherapy and background sensitivity to postoperative and chemotherapy-induced nausea and vomiting. Janicki PK; Sugino S Exp Brain Res; 2014 Aug; 232(8):2613-25. PubMed ID: 24792505 [TBL] [Abstract][Full Text] [Related]
25. A prospective, randomized, double-blind, and multicenter trial of prophylactic effects of ramosetronon postoperative nausea and vomiting (PONV) after craniotomy: comparison with ondansetron. Ryu JH; Lee JE; Lim YJ; Hong DM; Park HP; Han JI; Baik HJ; Kim HZ; Min KT; Do SH BMC Anesthesiol; 2014; 14():63. PubMed ID: 25104916 [TBL] [Abstract][Full Text] [Related]
26. Comparison of ramosetron with ondansetron for prevention of postoperative nausea and vomiting in patients undergoing gynaecological surgery. Kim SI; Kim SC; Baek YH; Ok SY; Kim SH Br J Anaesth; 2009 Oct; 103(4):549-53. PubMed ID: 19700442 [TBL] [Abstract][Full Text] [Related]
27. A review of granisetron, 5-hydroxytryptamine3 receptor antagonists, and other antiemetics. Hsu ES Am J Ther; 2010; 17(5):476-86. PubMed ID: 20844345 [TBL] [Abstract][Full Text] [Related]
28. Pediatric CYP2D6 metabolizer status and post-tonsillectomy nausea and vomiting after ondansetron. Black K; Brenn BR; Gaedigk A; Wanderer JP; Van Driest SL Clin Transl Sci; 2023 Feb; 16(2):269-278. PubMed ID: 36350309 [TBL] [Abstract][Full Text] [Related]
29. Patient-tailored antiemetic treatment with 5-hydroxytryptamine type 3 receptor antagonists according to cytochrome P-450 2D6 genotypes. Kaiser R; Sezer O; Papies A; Bauer S; Schelenz C; Tremblay PB; Possinger K; Roots I; Brockmöller J J Clin Oncol; 2002 Jun; 20(12):2805-11. PubMed ID: 12065557 [TBL] [Abstract][Full Text] [Related]
30. Dolasetron versus ondansetron for the treatment of postoperative nausea and vomiting. Meyer TA; Roberson CR; Rajab MH; Davis J; McLeskey CH Anesth Analg; 2005 Feb; 100(2):373-377. PubMed ID: 15673860 [TBL] [Abstract][Full Text] [Related]
31. The efficacy and cost-effectiveness of prophylactic 5-hydroxytryptamine3 receptor antagonists: tropisetron, ondansetron and dolasetron. Paech MJ; Rucklidge MW; Banks SL; Gurrin LC; Orlikowski CE; Pavy TJ Anaesth Intensive Care; 2003 Feb; 31(1):11-7. PubMed ID: 12635388 [TBL] [Abstract][Full Text] [Related]
32. Ondansetron and Granisetron for prevention of postoperative nausea and vomiting following laparoscopic cholecystectomy. Gauchan S; Thapa C; Shakya P; Bhattarai R; Shakya S JNMA J Nepal Med Assoc; 2014; 52(193):682-6. PubMed ID: 26905548 [TBL] [Abstract][Full Text] [Related]
33. The safety and efficacy of prophylactic ondansetron in patients undergoing modified radical mastectomy. Sadhasivam S; Saxena A; Kathirvel S; Kannan TR; Trikha A; Mohan V Anesth Analg; 1999 Dec; 89(6):1340-5. PubMed ID: 10589605 [TBL] [Abstract][Full Text] [Related]
34. Systematic review of ondansetron for the prevention and treatment of postoperative nausea and vomiting in adults. Cox F Br J Theatre Nurs; 1999 Dec; 9(12):556-63, 566. PubMed ID: 10887851 [TBL] [Abstract][Full Text] [Related]
35. Efficacy of single-dose intravenous dolasetron versus ondansetron in the prevention of postoperative nausea and vomiting. Walker JB Clin Ther; 2001 Jun; 23(6):932-8. PubMed ID: 11440292 [TBL] [Abstract][Full Text] [Related]
36. Comparison of Ramosetron With Ondansetron for Prevention of Intrathecal Morphine-Induced Nausea and Vomiting After Primary Total Knee Arthroplasty: A Randomized Control Trial. Pinsornsak P; Teeyaphudit M; Ruetiwarangkoon C; Chaiwuttisak A J Arthroplasty; 2017 Mar; 32(3):1040-1043. PubMed ID: 27816366 [TBL] [Abstract][Full Text] [Related]
37. Antiemetic prophylaxis for office-based surgery: are the 5-HT3 receptor antagonists beneficial? Tang J; Chen X; White PF; Wender RH; Ma H; Sloninsky A; Naruse R; Kariger R; Webb T; Zaentz A Anesthesiology; 2003 Feb; 98(2):293-8. PubMed ID: 12552184 [TBL] [Abstract][Full Text] [Related]
38. Prophylactic ondansetron for postoperative emesis. Meta-analysis of its effectiveness in patients with previous history of postoperative nausea and vomiting. Figueredo E; Canosa L Acta Anaesthesiol Scand; 1999 Jul; 43(6):637-44. PubMed ID: 10408818 [TBL] [Abstract][Full Text] [Related]
39. Comparison of vestipitant with ondansetron for the treatment of breakthrough postoperative nausea and vomiting after failed prophylaxis with ondansetron. Kranke P; Thompson JP; Dalby PL; Eberhart LH; Novikova E; Johnson BM; Russ SF; Noble R; Brigandi RA Br J Anaesth; 2015 Mar; 114(3):423-9. PubMed ID: 25488303 [TBL] [Abstract][Full Text] [Related]
40. Management of postoperative nausea and vomiting in patients undergoing laparoscopic cholecystectomy. Fujii Y Surg Endosc; 2011 Mar; 25(3):691-5. PubMed ID: 20927550 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]